To evaluate the effect of hydroxyapatite coating on cementless femoral stem, a prospective randomized clinical trial was conducted. A total of 84 hips from 69 patients were assigned to a hydroxyapatite/tricalcium-phosphate-coated group or a noncoated group. Thirty-two patients (37 hips) who received hydroxyapatite/tricalcium-phosphate-coated stems and 31 patients (38 hips) who received noncoated stems were followed for an average of 127 months.
View Article and Find Full Text PDFBackground: The hypothesis that the combined necrotic angle measurement from magnetic resonance imaging scans predicts the subsequent risk of collapse in hips with femoral head necrosis was tested.
Methods: Thirty-seven hips with early stage osteonecrosis in thirty-three consecutive patients were investigated. With use of the modified method of Kerboul et al.